Aflac Incorporated (AFL)

Market Cap	61.24B
Revenue (ttm)	17.30B
Net Income (ttm)	3.81B
Shares Out	555.53M
EPS (ttm)	6.65
PE Ratio	16.58
Forward PE	15.66
Dividend	$2.00 (1.81%)
Ex-Dividend Date	Nov 20, 2024

Volume	1,339,571
Open	110.97
Previous Close	110.63
Day's Range	109.78 - 111.16
52-Week Range	75.08 - 115.50
Beta	0.96
Analysts	Hold
Price Target	99.64 (-9.62%)
Earnings Date	Oct 30, 2024

About AFL

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term ...

• Industry: Insurance - Life
• Sector: Financials
• Founded: 1955
• Employees: 12,785
• Stock Exchange: NYSE
• Ticker Symbol: AFL
• Website: https://www.aflac.com

Financial Performance

In 2023, Aflac's revenue was $18.70 billion, a decrease of -2.29% compared to the previous year's $19.14 billion. Earnings were $4.66 billion, an increase of 5.45%.

Analyst Forecast

According to 14 analysts, the average rating for AFL stock is "Hold." The 12-month stock price forecast is $99.64, which is a decrease of -9.62% from the latest price.

Price Target

$99.64

(-9.62% downside)

Analyst Consensus: Hold